Marsh & McLennan Companies (NYSE:MRSH) Stock Gets Price Target Boost from UBS Group

Marsh & McLennan Companies (NYSE:MRSH) had its target price hoisted by analysts at UBS Group from $216.00 to $222.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. UBS Group’s target price suggests a potential upside of 27.93% from the stock’s previous close.

A number of other equities analysts have also commented on the stock. Mizuho boosted their price target on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a “neutral” rating in a research report on Wednesday, July 22nd. Citigroup cut shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price for the company. in a research note on Wednesday, July 22nd. Morgan Stanley boosted their target price on Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 19th. Weiss Ratings upgraded Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. Finally, Cantor Fitzgerald lifted their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $202.12.

Marsh & McLennan Companies Stock Performance

Shares of NYSE MRSH opened at $173.53 on Tuesday. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $207.82. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.14 and a current ratio of 1.14. The firm’s fifty day moving average is $182.82. The company has a market capitalization of $82.81 billion, a PE ratio of 21.21, a PEG ratio of 2.38 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.89 by $0.07. The business had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. Analysts predict that Marsh & McLennan Companies will post 10.43 earnings per share for the current year.

Insider Activity

In other Marsh & McLennan Companies news, insider Martin South sold 7,100 shares of the company’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the transaction, the insider owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Paul Beswick sold 713 shares of the stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the transaction, the senior vice president owned 16,376 shares in the company, valued at $3,242,448. The trade was a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 19,813 shares of company stock valued at $3,597,903 over the last three months. 0.38% of the stock is owned by insiders.

Hedge Funds Weigh In On Marsh & McLennan Companies

Large investors have recently made changes to their positions in the company. Focus Partners Advisor Solutions LLC acquired a new position in Marsh & McLennan Companies during the 2nd quarter valued at about $2,153,000. Daiichi Life Insurance Co. Ltd. acquired a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $3,880,000. Korea Investment CORP bought a new stake in shares of Marsh & McLennan Companies during the second quarter worth approximately $46,856,000. Bank of Nova Scotia acquired a new position in Marsh & McLennan Companies in the second quarter valued at approximately $20,681,000. Finally, Essex LLC bought a new position in Marsh & McLennan Companies in the first quarter valued at approximately $2,891,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.